EMN vs HGYN: stock comparison and AI forecast
Eastman Chemical Co (EMN) and Hong Yuan Holding Group (HGYN) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
EMN Eastman Chemical Co
- Price
- $64.41 -13.7% · 6M
- Market Cap
- $7.37B
- P/E Ratio
- 13.7x
- Size
- mid-cap
- AI Forecast
HGYN Hong Yuan Holding Group
- Price
- $0.03 -74.5% · 6M
- Market Cap
- n/a
- P/E Ratio
- –
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- Over the last six months EMN returned -13.7% and HGYN -74.5%.
- EMN turns 7.2% of its revenue into net income, against -15.3% for HGYN.
- EMN yields 5.19% in dividends; HGYN pays none.
- Both companies share the SEC industry classification Plastic Materials, Synth Resins & Nonvulcan Elastomers.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | EMN | HGYN |
|---|---|---|
| Market Cap | $7.37B | – |
| P/E Ratio | 13.68x | – |
| P/B Ratio | 1.17x | – |
| Dividend Yield | 5.19% | – |
| EPS | $4.71 | $0.00 |
| Book Value/Share | $54.87 | – |
| Revenue/Share | $79.10 | – |
| FCF/Share | $4.10 | – |
Profitability & Margins
| Metric | EMN | HGYN |
|---|---|---|
| ROE | 10.3% | – |
| ROA | 4.2% | -14.3% |
| ROIC | – | 96.9% |
| Gross Margin | 20.6% | – |
| Operating Margin | – | -23.6% |
| Net Margin | 7.2% | -15.3% |
| EBT Margin | 7.2% | -23.6% |
| Tax Rate | 0.6% | – |
Financial Health
| Metric | EMN | HGYN |
|---|---|---|
| Current Ratio | 1.57x | 0.78x |
| Quick Ratio | 0.79x | 0.73x |
| D/E Ratio | 1.45x | – |
| Financial Leverage | 2.46x | – |
| Interest Coverage | -16.5x | -0.8x |
| Working Capital | $1.59B | -$170K |
Cash Flow
| Metric | EMN | HGYN |
|---|---|---|
| Operating Cash Flow | $879M | – |
| Free Cash Flow | $469M | – |
| Capital Spending | -$410M | – |
| OCF Growth YoY | -12.8% | – |
| FCF Growth YoY | 18.7% | – |
| FCF/Sales | 5.2% | – |
| CapEx/Sales | 4.5% | – |
Operational Efficiency
| Metric | EMN | HGYN |
|---|---|---|
| Asset Turnover | 0.59x | – |
| Receivables Turnover | 8.5x | – |
| Inventory Turnover | 3.3x | – |
| Fixed Assets Turnover | 1.6x | – |
| Days Sales Outstanding | 43 days | – |
| Days Inventory | 111 days | – |
Income Statement
| Metric | EMN | HGYN |
|---|---|---|
| Total Revenue | $9.05B | – |
| Operating Income | – | -$140K |
| Net Income | $647M | -$90K |
| R&D Expense | $246M | – |
| SG&A Expense | $693M | – |
| Cost of Goods Sold | $7.19B | – |
Dividend & Shareholder Information
| Metric | EMN | HGYN |
|---|---|---|
| Dividends Per Share | $3.34 | – |
| Payout Ratio | 70.9% | – |
| Shares Outstanding | 114M | – |
| Net Income Growth | -7.4% | – |
| EPS Growth | -21.2% | – |
EMN vs HGYN: stock comparison and AI forecast
Which stock performed better over the last six months, EMN or HGYN?
Over the last six months EMN returned -13.7% and HGYN -74.5%.
Which one does Intratio's AI model rank higher, EMN or HGYN?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.